Japanese Society of Medical Oncology
Japan's medical oncology society, which certifies Japan's medical oncologists, holds a large annual meeting and publishes clinical guidelines with the Japan Society of Clinical Oncology.
Founded in 2002 from the earlier Japanese Society of Medical Oncology study group, JSMO established medical oncology as a board-certified specialty in Japan and now has more than 10,000 members. Its annual meeting, held in English and Japanese, presents Japanese trial data and hosts joint sessions with ASCO, ESMO and the Korean and Chinese societies, and it publishes guidelines on cancer genomic profiling, molecular testing, febrile neutropenia and antiemetics together with the Japan Society of Clinical Oncology. JSMO has been central to Japan's national programme of comprehensive genomic profiling under public insurance and to the certification of core cancer genomic medicine hospitals.
- Board certification of medical oncologists
- JSMO Annual Meeting
- Clinical guidelines (with JSCO)
- Cancer genomic medicine policy
Leads CIRCULATE-Japan, the largest ctDNA-guided adjuvant programme in colorectal cancer, and the PARADIGM and SCRUM-Japan GI efforts.
Thoracic oncologist who leads NCC Hospital in Tokyo and has been a Japanese principal investigator on a generation of lung cancer trials.
Pages like this
not linked directly; found by shared links- PersonShunji Takahashi
Shares Cancer Institute Hospital of JFCR, Comprehensive genomic profiling.
- InstitutionKyushu University Hospital
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Comprehensive genomic profiling.
- PersonHaruhiko Fukuda
Shares Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital.
- InstitutionNational Cancer Center Hospital East
Shares Takayuki Yoshino, Japan Clinical Oncology Group (JCOG), National Cancer Center Hospital, Comprehensive genomic profiling.
- PersonHitoshi Nakagama
Shares National Cancer Center Hospital, Comprehensive genomic profiling.
- InstitutionKyoto University Hospital
Shares Japanese oncology guidelines (JSMO, JSCO and organ societies), Japan Clinical Oncology Group (JCOG).
- IdeaCap public prices for new cancer drugs to tiers of the ESMO and ASCO value scales
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO).
- IdeaMicro-learning pushed to community oncologists within 30 days of a practice change
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO).